[HTML][HTML] Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
The persisting risk of long-term health consequences of SARS-CoV-2 infection and the
protection against such risk conferred by COVID-19 vaccination remains unclear. Here we …
protection against such risk conferred by COVID-19 vaccination remains unclear. Here we …
[HTML][HTML] The humoral response and antibodies against SARS-CoV-2 infection
Two and a half years into the COVID-19 pandemic, we have gained many insights into the
human antibody response to the causative SARS-CoV-2 virus. In this Review, we …
human antibody response to the causative SARS-CoV-2 virus. In this Review, we …
Impact of COVID-19 on vaccination programs: adverse or positive?
I Ali - Human vaccines & immunotherapeutics, 2020 - Taylor & Francis
The COVID-19 pandemic has posed multiple substantial challenges, affecting not only
public health but also economic systems, socio-cultural patterns, and political institutions …
public health but also economic systems, socio-cultural patterns, and political institutions …
[HTML][HTML] COVID-19 pandemic and vaccines update on challenges and resolutions
The coronavirus disease (COVID-19) is caused by a positive-stranded RNA virus called
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
[HTML][HTML] The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study
Background Symptoms of post-acute sequelae of COVID-19 (PASC) may improve following
SARS-CoV-2 vaccination. However few prospective data that also explore the underlying …
SARS-CoV-2 vaccination. However few prospective data that also explore the underlying …
[HTML][HTML] Peculiarities of the T cell immune response in COVID-19
D Kudlay, I Kofiadi, M Khaitov - Vaccines, 2022 - mdpi.com
Understanding the T cell response to SARS-CoV-2 is critical to vaccine development,
epidemiological surveillance, and control strategies for this disease. This review provides …
epidemiological surveillance, and control strategies for this disease. This review provides …
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that have
mutations associated with increased transmission and antibody escape have arisen over the …
mutations associated with increased transmission and antibody escape have arisen over the …
[HTML][HTML] SARS-CoV-2 vaccines: status report
F Amanat, F Krammer - Immunity, 2020 - cell.com
SARS-CoV-2, the causal agent of COVID-19, first emerged in late 2019 in China. It has since
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …
Principles and challenges in anti-COVID-19 vaccine development
Z Strizova, J Smetanova, J Bartunkova… - International Archives of …, 2021 - karger.com
The number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected
patients keeps rising in most of the European countries despite the pandemic precaution …
patients keeps rising in most of the European countries despite the pandemic precaution …
[HTML][HTML] Global acceptance and hesitancy of COVID-19 vaccination: A narrative review
W Hassan, SK Kazmi, MJ Tahir, I Ullah, HA Royan… - Narra J, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a major global health threat to human civilization …
syndrome coronavirus 2 (SARS-CoV-2), is a major global health threat to human civilization …